Why Is Apretude So Hard to Find? [Explained for 2026]

You've got a prescription for Apretude — the every-two-months injectable PrEP — and you're wondering why your pharmacy has no idea what you're talking about. You're not imagining things. Apretude is genuinely difficult to access in many parts of the United States, even though it's not in an official FDA drug shortage.

Here's the honest explanation — and what steps you can take to actually get it.

Is Apretude Actually in a Shortage?

As of 2026, Apretude (cabotegravir extended-release injectable suspension) is not listed on the FDA Drug Shortage Database. ViiV Healthcare, the manufacturer, continues to produce and distribute it. There is no documented manufacturing disruption or recall.

But "not in a shortage" doesn't mean "easy to get." The access barriers for Apretude are structural — rooted in how it's delivered, how it's billed, and which providers are equipped to administer it.

Why Apretude Isn't Stocked at Your Local Pharmacy

Unlike oral PrEP pills like Truvada or Descovy, Apretude is not a medication you pick up at a pharmacy counter. It's a 600 mg intramuscular injection administered by a healthcare professional directly into the gluteal muscle. This changes the entire supply chain.

There are a few reasons your corner pharmacy doesn't carry it:

It's a specialty injectable. Apretude must be stored and handled appropriately and administered in a clinical setting. Most retail pharmacies are not set up for this.

It's billed as a medical benefit. Because it's administered in a clinical setting, Apretude is often billed through your medical insurance — not your pharmacy benefit. This means it's acquired by the clinic or through a specialty pharmacy that ships directly to the provider.

Not all clinics have built the infrastructure. Community health centers, sexual health clinics, and primary care offices need specific training, supply chain arrangements, and billing workflows to administer injectable PrEP. Many are still getting there.

Insurance approval can take weeks. Even with ACA coverage mandates, it typically takes 2-4 weeks for prior authorization and insurance approval to come through before the first injection.

The Billing Complexity Problem

One reason Apretude access lags behind oral PrEP is billing complexity. Each Apretude injection visit involves three separately billed components: the medication itself (acquired through specialty pharmacy or directly by the clinic), the injection administration (billed as a procedure), and the clinical visit (covering HIV testing, counseling, and monitoring).

Practices must navigate whether to bill under the medical or pharmacy benefit, and which specialty pharmacies to work with. This takes time and administrative capacity that not all practices have invested in yet.

Why Apretude Availability Varies So Much by Location

Access to Apretude is highly dependent on your geographic area and the healthcare infrastructure around you. Major urban centers — particularly cities with robust HIV prevention programs — tend to have more providers offering injectable PrEP. Rural areas and smaller cities often have fewer options.

Even within a single metro area, some clinics have fully integrated Apretude into their workflows while others are still in the planning stages. Factors like federal Ryan White funding, state HIV prevention programs, and local health department support all influence how quickly injectable PrEP becomes available at community clinics.

Who Can Prescribe and Administer Apretude?

Any licensed prescriber can write a prescription for Apretude — infectious disease specialists, primary care physicians, OB/GYNs, nurse practitioners, and physician assistants who are familiar with PrEP guidelines. However, the injection itself must be administered in a clinical setting by a trained healthcare professional.

This is a key difference from oral PrEP: you can't take Apretude home. Every dose requires an in-person appointment, an HIV test before each injection, and the right equipment. This is by design — it ensures safety and allows for real-time HIV testing before each injection, which is medically required due to the drug's boxed warning.

The Pharmacokinetic 'Tail' — Why Missed Doses Matter So Much

Apretude has an unusually long pharmacokinetic profile: residual concentrations of cabotegravir can remain in your system for up to 12 months or longer after the last injection. This matters for access in an important way.

If you miss a dose by more than 7 days, the FDA recommends a specific oral cabotegravir bridge protocol to maintain protection. If access issues cause you to miss injections altogether, those residual drug levels — while too low for full protection — can still exert drug pressure on the virus. This is why uninterrupted access to your provider is critical.

What You Can Do If You're Having Trouble Getting Apretude

Here are the most practical steps:

Ask your prescriber if their clinic stocks or orders Apretude. Many practices that can prescribe it also administer it in-house or work with a specialty pharmacy to deliver it.

Contact your state or local health department. Many have programs specifically to support injectable PrEP access, especially for uninsured or underinsured patients.

Look for an HIV specialty clinic or Ryan White-funded health center. These typically have the infrastructure to administer injectable PrEP.

Use medfinder to locate providers.

Enroll in ViiVConnect. ViiV Healthcare's patient support program (ViiVConnect.com) can help navigate insurance, specialty pharmacy logistics, and financial assistance.

Don't Go Without Protection While You Wait

If you're waiting on Apretude access to be sorted out, don't go unprotected. Daily oral PrEP options (generic Truvada, Descovy) are widely available and highly effective — and many providers can bridge you to injectable PrEP once everything is in place. See our guide to alternatives to Apretude if you can't fill your prescription for more options.

medfinder helps patients find medications and locate providers. Visit medfinder.com to get started.